Proto Labs (WBO:PRLB) Other Long-Term Liabilities: €3.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:PRLB Proto Labs Inc WBO:PRLB
62 GF Score
Price €69.05
GF Value €39.91
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Proto Labs Other Long-Term Liabilities?

Proto Labs WBO:PRLB +5.90% 62 Other Long-Term Liabilities is €3.9 Mil as of Jun. 2026. GuruFocus rates WBO:PRLB with a GF Score™ of 62/100 and a GF Value™ of €39.91 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Proto Labs's other long-term liabilities for the quarter that ended in Jun. 2026 was €3.9 Mil.

Proto Labs's quarterly other long-term liabilities increased from Dec. 2025 (€3.7 Mil) to Mar. 2026 (€3.8 Mil) and increased from Mar. 2026 (€3.8 Mil) to Jun. 2026 (€3.9 Mil).

Proto Labs's annual other long-term liabilities declined from Dec. 2023 (€4.6 Mil) to Dec. 2024 (€4.4 Mil) and declined from Dec. 2024 (€4.4 Mil) to Dec. 2025 (€3.7 Mil).

Proto Labs Other Long-Term Liabilities Related Terms

Proto Labs Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Proto Labs's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Labs Other Long-Term Liabilities Chart

Proto Labs Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.05 4.12 4.62 4.40 3.65

Proto Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.44 4.40 3.65 3.80 3.95
WBO:PRLB
62GF Score
Proto Labs Inc WBO:PRLB
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Proto Labs Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of €3.9 Mil mean?
Proto Labs (WBO:PRLB) has a Other Long-Term Liabilities of €3.9 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Proto Labs and its competitors.
Is Proto Labs' Other Long-Term Liabilities too high?
Proto Labs' current Other Long-Term Liabilities is €3.9 Mil. Overall, Proto Labs has a GF Score™ of 62/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Proto Labs' Other Long-Term Liabilities compare to RYZ and WOR?
Proto Labs' Other Long-Term Liabilities of €3.9 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for an Industrial Products company?
A good Other Long-Term Liabilities depends on the Industrial Products industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Proto Labs and its competitors. Proto Labs's current Other Long-Term Liabilities is €3.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Labs stock overvalued right now?
Based on GuruFocus' analysis, Proto Labs (WBO:PRLB) is currently considered Significantly Overvalued. The stock's GF Value™ is €39.91, compared to a current price of €69.05 — trading 73% above its estimated fair value. The current Other Long-Term Liabilities is €3.9 Mil. Proto Labs' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Proto Labs (WBO:PRLB), the current Other Long-Term Liabilities is €3.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Proto Labs (WBO:PRLB) Overvalued in 2026?

Based on GuruFocus' analysis, Proto Labs stock appears to be overvalued. The current stock price of €69.05 is trading 73% above its estimated GF Value™ of €39.91. GuruFocus considers Proto Labs to be Significantly Overvalued.

Key valuation signals for WBO:PRLB:

  • Other Long-Term Liabilities: €3.9 Mil
  • GF Value™: €39.91 vs. price of €69.05 (73% above fair value)
  • GF Score™: 62/100 with 7 warning signs

No single metric tells the full story. See the WBO:PRLB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Proto Labs Business Description

Other Exchanges PRLB:USA0KRR:UKPRZ:Germany
Address 5540 Pioneer Creek Drive, Maple Plain, MN, USA, 55359
Proto Labs Inc is an on-demand manufacturer of custom parts for prototyping and short-run production. The company offers developers and engineers quick-turn production services to reduce the time to market. The Lab uses injection molding, computer numerical control machining, and 3-D printing, and sheet metal to manufacture custom parts for its clients. The company services clients' needs for prototype solutions, parts for testing procedures, bridge production capabilities during disruptions in manufacturing processes, limited-quantity requests, and end-of-life production support. Geographically, a majority of the company's revenue is derived from the United States and the rest from Europe.
62GF Score

Get the complete analysis for WBO:PRLB

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€69.05
Price
€39.91
GF Value